awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38804812-69EDC99A-F898-4682-8FFF-E6E1362377A2
Q38804812-69EDC99A-F898-4682-8FFF-E6E1362377A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38804812-69EDC99A-F898-4682-8FFF-E6E1362377A2
Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-
P2860
Q38804812-69EDC99A-F898-4682-8FFF-E6E1362377A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38804812-69EDC99A-F898-4682-8FFF-E6E1362377A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d9af0bac3785455d494764229e62c3cbe4a63e2d
P2860
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab